Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 September 2021 | Story Michelle Nöthling | Photo Supplied
Emily Matabane.

“I love teaching hearing people Sign Language,” Emily immediately mentions when asked about herself, “so that they can communicate with Deaf people and work with them.” Part of her passion, though, was borne from personal hardship. Emily had a difficult experience when she entered the work environment in 2000, since she was the only Deaf person among an all-hearing staff. Can one even begin to imagine the frustration and isolation she must have experienced? It is no wonder, then, that her vision is for Deaf people to have equal access to information, and for the hearing and Deaf to be able to communicate with each other more freely. And the latter she is pursuing with all her energy.

“When I started working as a Teaching Assistant in the UFS Department of South African Sign Language (SASL) and Deaf Studies,” Emily recalls, “few students were interested in studying Sign Language, because they were not aware of Deaf people and Sign Language.” This has started to change, though, as Emily is noticing a drastic increase in the number of UFS students enrolling for SASL. “I am now familiar with a lot of hearing student who have done Sign Language at our university, and they are very friendly when I meet them. Also, because they are able to greet me in Sign Language!” It is important to note that the department teaches SASL modules to both Deaf and hearing students (and staff) who want to learn the language – which is now also available as an online option.

As a second-year student studying BEd, Emily has formed a close relationship with CUADS (Centre for Universal Access and Disability Support) at the UFS. “CUADS is doing a great job in assisting students with disabilities and catering for their needs. They assist students to have access to education on the same level as other students without disabilities.”

Sign Language is of vital importance to the Deaf community, since it is the language of accessibility for Deaf people. “We are proud and acknowledge Sign Language as a medium of communication,” says Emily. “It allows us to express ourselves, and to teach and transfer our Deaf culture from one generation to the other.”

Ultimately, Emily is hopeful that Sign Language will become embraced, celebrated, and recognised as equal to the other official languages in South Africa.

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept